SG11201703201PA - Piperidinylpyrazolopyrimidinones and their use - Google Patents
Piperidinylpyrazolopyrimidinones and their useInfo
- Publication number
- SG11201703201PA SG11201703201PA SG11201703201PA SG11201703201PA SG11201703201PA SG 11201703201P A SG11201703201P A SG 11201703201PA SG 11201703201P A SG11201703201P A SG 11201703201PA SG 11201703201P A SG11201703201P A SG 11201703201PA SG 11201703201P A SG11201703201P A SG 11201703201PA
- Authority
- SG
- Singapore
- Prior art keywords
- piperidinylpyrazolopyrimidinones
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D247/00—Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups C07D229/00 - C07D245/00
- C07D247/02—Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups C07D229/00 - C07D245/00 having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14191410 | 2014-11-03 | ||
| EP15165918 | 2015-04-30 | ||
| PCT/EP2015/075208 WO2016071216A1 (en) | 2014-11-03 | 2015-10-30 | Piperidinylpyrazolopyrimidinones and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201703201PA true SG11201703201PA (en) | 2017-05-30 |
Family
ID=54365247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201703201PA SG11201703201PA (en) | 2014-11-03 | 2015-10-30 | Piperidinylpyrazolopyrimidinones and their use |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10118930B2 (ja) |
| EP (1) | EP3215505B1 (ja) |
| JP (1) | JP2017533235A (ja) |
| KR (1) | KR20170080647A (ja) |
| CN (1) | CN107108638A (ja) |
| AU (1) | AU2015342021B2 (ja) |
| BR (1) | BR112017009207A2 (ja) |
| CA (1) | CA2966259A1 (ja) |
| HK (1) | HK1243077A1 (ja) |
| IL (1) | IL251335A0 (ja) |
| MX (1) | MX2017005586A (ja) |
| PE (1) | PE20170920A1 (ja) |
| RU (1) | RU2713937C2 (ja) |
| SG (1) | SG11201703201PA (ja) |
| TW (1) | TW201627308A (ja) |
| UY (1) | UY36385A (ja) |
| WO (1) | WO2016071216A1 (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7178357B2 (ja) * | 2017-03-07 | 2022-11-25 | エフ．ホフマン－ラ ロシュ アーゲー | オキサジアゾール一過性受容器電位チャネル阻害剤 |
| WO2018224455A1 (en) | 2017-06-07 | 2018-12-13 | Basf Se | Substituted cyclopropyl derivatives |
| US11654057B2 (en) | 2020-04-09 | 2023-05-23 | Bio 54, Llc | Devices for bleeding reduction and methods of making and using the same |
| TWI803177B (zh) * | 2021-02-05 | 2023-05-21 | 大陸商賽諾哈勃藥業（成都）有限公司 | 一種纖維蛋白溶酶抑制劑、其製備方法及應用 |
| US11642324B1 (en) | 2022-03-01 | 2023-05-09 | Bio 54, Llc | Topical tranexamic acid compositions and methods of use thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU229024B1 (en) | 1996-07-24 | 2013-07-29 | Bristol Myers Squibb Pharma Co | Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof |
| US7550470B2 (en) | 2002-12-11 | 2009-06-23 | Merck & Co. Inc. | Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors |
| EA200501888A1 (ru) * | 2003-06-03 | 2006-06-30 | Басф Акциенгезельшафт | Замещённые пиразолопиримидины, способ их получения и их применение для борьбы с патогенными грибами, а также содержащие их средства |
| WO2006023001A1 (en) | 2004-07-30 | 2006-03-02 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
| RU2390523C2 (ru) * | 2005-10-21 | 2010-05-27 | Мицубиси Танабе Фарма Корпорейшн | ПРОИЗВОДНОЕ ПИРАЗОЛ[1,5-a]ПИРИМИДИНА |
| EP1873157A1 (en) * | 2006-06-21 | 2008-01-02 | Bayer Schering Pharma Aktiengesellschaft | Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| PE20121506A1 (es) | 2006-07-14 | 2012-11-26 | Amgen Inc | Compuestos triazolopiridinas como inhibidores de c-met |
| JP2009544625A (ja) | 2006-07-20 | 2009-12-17 | メーメット・カーラマン | Ｒｈｏキナーゼのベンゾチオフェン阻害剤 |
| WO2009017954A1 (en) | 2007-08-01 | 2009-02-05 | Phenomix Corporation | Inhibitors of jak2 kinase |
| WO2009023179A2 (en) | 2007-08-10 | 2009-02-19 | Genelabs Technologies, Inc. | Nitrogen containing bicyclic chemical entities for treating viral infections |
| CA2706946A1 (en) | 2007-11-28 | 2009-06-04 | Schering Corporation | 2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
| CN102459246B (zh) | 2009-04-07 | 2014-05-07 | 阿斯利康(瑞典)有限公司 | 作为治疗剂的异噁唑-3(2h)-酮类似物 |
| EP2566333A4 (en) | 2010-05-07 | 2014-04-02 | Univ Leland Stanford Junior | IDENTIFICATION OF STABILIZERS OF MULTIMEDER PROTEINS |
| WO2012047156A1 (en) * | 2010-10-04 | 2012-04-12 | Astrazeneca Ab | Isoxazol-3(2h)-one analogs as plasminogen inhibitors and their use in the treatment of fibrinolysis related diseases |
| CA2820362C (en) | 2010-12-08 | 2020-03-24 | The United States Of America, As Represented By The Secretary, Departmt Of Health And Human Services | Substituted pyrazolopyrimidines as glucocerebrosidase activators |
| US9440989B2 (en) * | 2012-07-18 | 2016-09-13 | Proyecto De Biomedicina Cima, S.L. | Antifibrinolytic compounds |
| JP6204568B2 (ja) * | 2013-04-25 | 2017-09-27 | ベイジーン，リミテッド | タンパク質キナーゼ阻害剤としての縮合複素環化合物 |
| UY35809A (es) * | 2013-11-05 | 2015-05-29 | Bayer Pharma AG | (aza)piridopirazolopirimidinonas e indazolopirimidinonas y sus usos |
-
2015
- 2015-10-30 KR KR1020177014874A patent/KR20170080647A/ko unknown
- 2015-10-30 JP JP2017523882A patent/JP2017533235A/ja active Pending
- 2015-10-30 RU RU2017119419A patent/RU2713937C2/ru not_active IP Right Cessation
- 2015-10-30 EP EP15788013.9A patent/EP3215505B1/en active Active
- 2015-10-30 MX MX2017005586A patent/MX2017005586A/es unknown
- 2015-10-30 TW TW104135708A patent/TW201627308A/zh unknown
- 2015-10-30 CA CA2966259A patent/CA2966259A1/en not_active Abandoned
- 2015-10-30 SG SG11201703201PA patent/SG11201703201PA/en unknown
- 2015-10-30 WO PCT/EP2015/075208 patent/WO2016071216A1/en active Application Filing
- 2015-10-30 BR BR112017009207A patent/BR112017009207A2/pt not_active Application Discontinuation
- 2015-10-30 US US15/523,954 patent/US10118930B2/en not_active Expired - Fee Related
- 2015-10-30 CN CN201580072218.0A patent/CN107108638A/zh active Pending
- 2015-10-30 PE PE2017000789A patent/PE20170920A1/es unknown
- 2015-10-30 AU AU2015342021A patent/AU2015342021B2/en not_active Expired - Fee Related
- 2015-11-03 UY UY0001036385A patent/UY36385A/es not_active Application Discontinuation
-
2017
- 2017-03-22 IL IL251335A patent/IL251335A0/en unknown
-
2018
- 2018-02-26 HK HK18102694.5A patent/HK1243077A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2966259A1 (en) | 2016-05-12 |
| JP2017533235A (ja) | 2017-11-09 |
| HK1243077A1 (zh) | 2018-07-06 |
| UY36385A (es) | 2016-06-01 |
| WO2016071216A1 (en) | 2016-05-12 |
| RU2017119419A3 (ja) | 2019-06-10 |
| CN107108638A (zh) | 2017-08-29 |
| PE20170920A1 (es) | 2017-07-12 |
| US10118930B2 (en) | 2018-11-06 |
| US20170334917A1 (en) | 2017-11-23 |
| TW201627308A (zh) | 2016-08-01 |
| EP3215505A1 (en) | 2017-09-13 |
| RU2017119419A (ru) | 2018-12-05 |
| KR20170080647A (ko) | 2017-07-10 |
| RU2713937C2 (ru) | 2020-02-11 |
| AU2015342021A1 (en) | 2017-05-04 |
| IL251335A0 (en) | 2017-05-29 |
| BR112017009207A2 (pt) | 2019-10-01 |
| MX2017005586A (es) | 2017-06-19 |
| AU2015342021B2 (en) | 2020-02-27 |
| EP3215505B1 (en) | 2019-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252216A0 (en) | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | |
| HK1231471A1 (zh) | -雜芳氧基-和 芳氧基-喹啉- -甲酰胺及其用途 | |
| GB201411197D0 (en) | Composition and use thereof | |
| PT3018183T (pt) | Composição à base de halo-olefina e sua utilização | |
| HUE044571T2 (hu) | Módosított ciklopentapeptidek és alkalmazásaik | |
| GB201401617D0 (en) | Novel combination and use | |
| IL264813B (en) | 2-oxo-imidazopyridines and their use | |
| HK1243950A1 (zh) | 新型組合物和用途 | |
| SG11201608943VA (en) | Substituted 4-phenylpiperidines, their preparaiton and use | |
| SG11201704473WA (en) | New methods and uses | |
| HK1243077A1 (zh) | 呱啶基吡唑並嘧啶酮及其用途 | |
| GB201416727D0 (en) | Use | |
| GB201416716D0 (en) | Use | |
| GB201411196D0 (en) | Composition and use thereof | |
| GB201408091D0 (en) | Methods and uses | |
| GB2545167B (en) | Cloches and use thereof | |
| PL3229772T3 (pl) | 6-arylo-9-glikozylopuryny i ich zastosowanie | |
| GB201514770D0 (en) | Compounds and their use | |
| GB201416073D0 (en) | Methods and uses | |
| GB201416086D0 (en) | Methods and uses | |
| GB201413411D0 (en) | Novel compounds and their use | |
| PT2923578T (pt) | Método para a produção de um produto alimentar | |
| GB201500278D0 (en) | Novel combination and use | |
| GB201404728D0 (en) | Disc-over incorporating disc-heads and disc-earning | |
| GB201421960D0 (en) | Use |